WallStreetZenWallStreetZen

NASDAQ: NTLA
Intellia Therapeutics Inc Stock Ownership - Who owns Intellia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Intellia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John M. LeonardCEO;Pres2026-11-029,000$11.99
$107.91kSell
Michael P. DubeCAO;VP2026-10-021,864$12.43
$23.17kSell
John M. LeonardCEO;Pres2026-08-212,785$13.00
$36.21kSell
John M. LeonardCEO;Pres2026-08-2019,890$12.60
$250.61kSell
Edward J. Dulac IiiCFO;EVP2026-07-228,111$11.25
$91.25kSell
Edward J. Dulac IiiEVP Chief Financial Officer2026-07-024,677$18.00
$84.19kSell
Michael P. DubeVP Chief Accounting Officer2026-07-012,641$16.78
$44.32kSell
Eliana ClarkEVP Chief Technical Officer2026-03-02607$13.78
$8.36kSell
James BastaEVP General Counsel2026-03-021,211$13.78
$16.69kSell
Birgit C. SchultesEVP Chief Scientific Officer2026-01-058,508$9.21
$78.36kSell

1 of 3

NTLA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NTLA insiders and whales buy or sell their stock.

NTLA Shareholders

What type of owners hold Intellia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rachel E. Haurwitz3.99%5,593,846$63.83MInsider
Caribou Therapeutics Holdco LLC3.99%5,593,846$63.83MInsider
Novartis Institutes For Biomedical Research Inc3.10%4,352,295$49.66MInsider
Caribou Biosciences Inc2.85%3,994,355$45.58MInsider
Atlas Venture Associates IX LP2.66%3,729,788$42.56MInsider
Atlas Venture Fund IX LP2.55%3,579,788$40.85MInsider
Carl L. Gordon1.90%2,662,180$30.38MInsider
Orbimed Advisors LLC1.90%2,662,180$30.38MInsider
Temasek Holdings Private Ltd0.91%1,281,054$14.62MInsider
John M. Leonard0.89%1,254,894$14.32MInsider

1 of 3

NTLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NTLA0.10%28.30%Net SellingNet Selling
NVAX0.07%17.13%Net Selling
NUVB0.07%45.22%Net BuyingNet Buying
RAPP0.09%34.56%Net BuyingNet Buying
ANAB0.07%99.93%Net SellingNet Buying
View Top Biotech Stocks

Intellia Therapeutics Stock Ownership FAQ

Who owns Intellia Therapeutics?

Intellia Therapeutics (NASDAQ: NTLA) is owned by 0.10% institutional shareholders, 28.30% Intellia Therapeutics insiders, and 71.59% retail investors. Rachel E. Haurwitz is the largest individual Intellia Therapeutics shareholder, owning 5.59M shares representing 3.99% of the company. Rachel E. Haurwitz's Intellia Therapeutics shares are currently valued at $59.02M.

If you're new to stock investing, here's how to buy Intellia Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.